If only they'd looked harder.
So, it turns out that one senior public official did look closely enough at the rebrand to have some objections, but they were to the necessity of the project and not the design itself
). Apparently, the department never asked for the rebrand so the official questioned whether it should have happened at all. Given this meant the design was given a second look, our minds are blown that no-one noticed the problem. We bet they wish they'd looked just a little bit harder at the actual design and not just the financials as it would have saved a lot of red faces, and a lot of upset tweets, too.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ruth Wishart: Tory hopefuls may be women, but they're not feministsTHE late author and journalist Rebecca West said this: “I myself have never been able to find out precisely what feminism is: I only know people…
Read more »
Low rate of COVID-19 vaccination among high-risk pregnant womenLow rate of COVID-19 vaccination among high-risk pregnant women Coronavirus Disease COVID WomensHealth Pregnancy UpstateNews UMBaltimore LiebertPub
Read more »
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women - Genome MedicineBackground Breast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of poor-prognostic breast cancers. However, it is not known if antagonising progesterone can prevent breast cancers in humans. We suggest that targeting progesterone signalling could be a means of reducing features which are known to promote breast cancer formation. Methods In healthy premenopausal women with and without a BRCA mutation we studied (i) estrogen and progesterone levels in saliva over an entire menstrual cycle (n= 20); (ii) cancer-free normal breast-tissue from a control population who had no family or personal history of breast cancer and equivalently from BRCA1/2 mutation carriers (n= 28); triple negative breast cancer (TNBC) biopsies and healthy breast tissue taken from sites surrounding the TNBC in the same individuals (n= 14); and biopsies of ER+ve/PR+ve stage T1–T2 cancers and healthy breast tissue taken from sites surrounding the cancer in the same individuals (n= 31); and (iii) DNA methylation and DNA mutations in normal breast tissue (before and after treatment) from clinical trials that assessed the potential preventative effects of vitamins and antiprogestins (mifepristone and ulipristal acetate; n= 44). Results Daily levels of progesterone were higher throughout the menstrual cycle of BRCA1/2 mutation carriers, raising the prospect of targeting progesterone signalling as a means of cancer risk reduction in this population. Furthermore, breast field cancerization DNA methylation signatures reflective of (i) the mitotic age of normal breast epithelium and (ii) the proportion of luminal progenitor cells were increased in breast cancers, indicating that luminal progenitor cells with elevated replicative age are more prone to malignant transformation. The progesterone receptor antagonist mifepristone reduced both the mitotic age and the proportion of luminal progenitor cells in normal
Read more »
Miss Diagnosed: the free handbook designed to help women advocate for their healthThe e-book Miss Diagnosed is part of a campaign to end the gender health gap by supporting women to advocate for themselves at the doctor.
Read more »